LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Gong, Zhaojian ^a,b,c   Zhang, Shanshan ^d   Zeng, Zhaoyang ^a,b,e   Wu, Hanjiang ^c   Yang, Qian ^b   Xiong, Fang ^b,d   Shi, Lei ^b,c   Yang, Jianbo ^a,f   Zhang, Wenling ^b,g   Zhou, Yanhong ^a,b   Zeng, Yong ^a   Li, Xiayu ^b,e   Xiang, Bo ^a,b   Peng, Shuping ^a,b   Zhou, Ming ^a,b   Li, Xiaoling ^a,b   Tan, Ming ^b,g   Li, Yong ^b,h   Xiong, Wei ^a,b,e   Li, Guiyuan ^a,b,e  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF SOUTH ALABAMA   (United States)

^h University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN D1; CYCLIN E; CYCLIN E1; LOC 401317; LONG UNTRANSLATED RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLASMID VECTOR; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EXPRESSION VECTOR; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MOUSE MODEL; NASOPHARYNX CARCINOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA GENE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; RNA, LONG NONCODING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84913529378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110674     Document Type: Article

References (50)

1. Guigay J (2008) Advances in nasopharyngeal carcinoma. Curr Opin Oncol 20: 264-269.
2. Zeng Z, Huang H, Zhang W, Xiang B, Zhou M, et al. (2011) Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci 54: 966-975.
3. Yang Y, Liao Q, Wei F, Li X, Zhang W, et al. (2013) LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One 8: e62869.
4. Liao Q, Zeng Z, Guo X, Li X, Wei F, et al. (2014) LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene 33: 2098-2109.
5. Zeng Z, Huang H, Huang L, Sun M, Yan Q, et al. (2014) Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci 57: 315-326.
6. He ML, Luo MX, Lin MC, Kung HF (2012) MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma. Biochim Biophys Acta 1825: 1-10.
7. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, et al. (2006) Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med 8: 156-160.
8. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, et al. (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64: 1972-1974.
9. Stoker SD, van Diessen JN, de Boer JP, Karakullukcu B, Leemans CR, et al. (2013) Current treatment options for local residual nasopharyngeal carcinoma. Curr Treat Options Oncol 14: 475-491.
10. Spratt DE, Lee N (2012) Current and emerging treatment options for nasopharyngeal carcinoma. Onco Targets Ther 5: 297-308.
11. Chan AT (2011) Current treatment of nasopharyngeal carcinoma. Eur J Cancer 47 Suppl 3:: S302-303.
12. Hock AK, Vousden KH (2012) Tumor suppression by p53: fall of the triumvirate? Cell 149: 1183-1185.
13. Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, et al. (2012) p53 dynamics control cell fate. Science 336: 1440-1444.
14. Kastan MB (2007) Wild-type p53: tumors can't stand it. Cell 128: 837-840.
15. Gong Z, Huang H, Xu K, Liang F, Li X, et al. (2012) Advances in microRNAs and TP53 Gene Regulatory Network. Prog Biochem Biophys 39: 1133-1144.
16. Levine AJ, Finlay CA, Hinds PW (2004) P53 is a tumor suppressor gene. Cell 116: S67-69, 61 p following S69.
17. Weissmueller S, Manchado E, Saborowski M, Morris JPt, Wagenblast E, et al. (2014) Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor beta Signaling. Cell 157: 382-394.
18. Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, et al. (2009) Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 27: 799-804.
19. Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136: 629-641.
20. Tang K, Wei F, Bo H, Huang H, Zhang W, et al. (2014) Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular carcinoma. Prog Biochem Biophys 41: 153-162.
21. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
22. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, et al. (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717-1720.
23. Martens JA, Laprade L, Winston F (2004) Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 429: 571-574.
24. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, et al. (2008) A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 22: 756-769.
25. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, et al. (2011) Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54: 1679-1689.
26. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, et al. (2013) Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol 44: 545-554.
27. Spizzo R, Almeida MI, Colombatti A, Calin GA (2012) Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31: 4577-4587.
28. Gong Z, Zhang S, Zhang W, Huang H, Li Q, et al. (2012) Long non-coding RNAs in cancer. Sci China Life Sci 55: 1120-1124.
29. Guttman M, Amit I, Garber M, French C, Lin MF, et al. (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227.
30. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, et al. (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43: 621-629.
31. Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, et al. (2013) The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 23: 340-350.
32. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, et al. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419.
33. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, et al. (2013) LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 41: 4976-4987.
34. Zeng Z, Zhou Y, Xiong W, Luo X, Zhang W, et al. (2007) Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol 133: 71-81.
35. Liao Q, Guo X, Li X, Li X, Chen P, et al. (2012) Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol 138: 57-64.
36. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, et al. (2007) Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 38: 120-133.
37. Ji P, Diederichs S, Wang W, Boing S, Metzger R, et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041.
38. Gibb EA, Brown CJ, Lam WL (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38.
39. Tinzl M, Marberger M, Horvath S, Chypre C (2004) DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol 46: 182-186; discussion 187.
40. Geng YJ, Xie SL, Li Q, Ma J, Wang GY (2011) Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 39: 2119-2128.
41. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, et al. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250.
42. Tsai MC, Spitale RC, Chang HY (2011) Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71: 3-7.
43. Nie Y, Liu X, Qu S, Song E, Zou H, et al. (2013) Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci 104: 458-464.
44. Gao W, Chan JY, Wong TS (2014) Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma. Biomed Res Int 2014: 404567.
45. Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, et al. (2008) An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood 112: 4235-4246.
46. Kumar M, Lu Z, Takwi AA, Chen W, Callander NS, et al. (2011) Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 30: 843-853.
47. Gutschner T, Diederichs S (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9: 703-719.
48. Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23: 1494-1504.
49. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358.
50. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, et al. (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147: 358-369.